The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Gastrointestinal Cancer|Head and Neck Cancer|Dihydropyrimidine Dehydrogenase Deficiency|UGT1A1 Gene Mutation|Breast Cancer
Interventions: OTHER: Availability of clinical decision support based on pharmacogenomic results.
Sponsor: University of Chicago